Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vecantoxatug (GR2001) in healthy subjects for tetanus prophylaxis
NCT06302374Phase 2Completed
- Sponsor
- Zhixiang Jintai
- Start
- Mar 2023
- Primary completion
- Nov 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of vecantoxatug in Tetanus, sponsored by Zhixiang Jintai. Started Mar 2023; status: completed.
02
Drugs
vecantoxatug
03
Conditions
Tetanus
Beyond the preview
Go deeper on NCT06302374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06302374.